Jantzen J P
Klinik für Anaesthesiologie, Johannes Gutenberg-Universität Mainz.
Anaesthesist. 1988 Aug;37(8):458-69.
General anesthesia has been in use for ophthalmic surgery since 1847. The subsequent predominance of local anesthetic techniques made ophthalmic anesthesia the "Cinderella of anesthesia services" until its clinical and scientific rehabilitation in the second half of this century. Precise control of intraocular tension is an accepted advantage of general anesthesia. The exercise of such control requires understanding of intraocular physiology and the effects exerted by anesthetic techniques. Hence, the impact of anesthetic drugs on intraocular pressure (IOP) must be considered when ophthalmic surgery is to be carried out under general anesthesia. Intravenous anesthetics and volatile agents reduce IOP, with the possible exception of ketamine. Underlying mechanisms include a direct effect on cerebral IOP control centers and indirect effects mediated through the balance between production and drainage of aqueous humor, general circulation and ocular muscle tone. IOP is likely to be elevated during induction and recovery. Currently suggested measures to prevent the increase in IOP associated with laryngoscopic tracheal intubation facilitated by succinylcholine include oral premedication with clonidine, intravenous administration of lidocaine 3 min prior to laryngoscopy, and anesthetic induction with propofol or narcotics. Non depolarizing neuromuscular blocking drugs either do not affect IOP or produce a slight decrease; depolarizing muscle relaxants increase IOP. It remains controversial whether this effect, which is pronounced with succinylcholine, may be reliably abolished by any concomitant medication. The new competitive relaxants atracurium and vecuronium provide stable conditions with respect to IOP and systemic circulation, combined with a rapid onset and intermediate duration of action.
自1847年以来,全身麻醉就已应用于眼科手术。随后局部麻醉技术占据主导地位,使得眼科麻醉成为“麻醉服务中的灰姑娘”,直至本世纪下半叶其在临床和科学领域得到复兴。精确控制眼内压是全身麻醉公认的优势。要实现这种控制,需要了解眼内生理学以及麻醉技术所产生的影响。因此,在全身麻醉下进行眼科手术时,必须考虑麻醉药物对眼内压(IOP)的影响。静脉麻醉药和挥发性麻醉剂可降低眼内压,但氯胺酮可能除外。其潜在机制包括对脑内眼内压控制中心的直接作用以及通过房水生成与引流、体循环和眼肌张力之间的平衡介导的间接作用。在诱导期和恢复期眼内压可能会升高。目前建议的预防与琥珀酰胆碱辅助喉镜气管插管相关的眼内压升高的措施包括口服可乐定进行术前用药、在喉镜检查前3分钟静脉注射利多卡因以及用丙泊酚或麻醉性镇痛药进行麻醉诱导。非去极化神经肌肉阻滞药要么不影响眼内压,要么使其略有降低;去极化肌松药会使眼内压升高。琥珀酰胆碱引起的这种明显效应是否能被任何辅助用药可靠消除仍存在争议。新型竞争性肌松药阿曲库铵和维库溴铵在眼内压和体循环方面提供稳定条件,起效迅速且作用持续时间适中。